Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.
Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.
Active, not recruiting · NCT05035212 · Registry updated 2026-01-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. | Lower Respiratory Tract Illness | Active, not recruiting | Phase 3 | 2026-01-28 | NCT05035212 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pfizer | 431 |
262 results · Page 1 of 11
Research sites
Swipe the table sideways for more columns.